BIOTHEUS
Biotheus is an up-and-coming biotech company focused on curing malignant tumors and autoimmune diseases. Biotheus is committed to research and development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies.
BIOTHEUS
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Zhuhai, Guangdong, China
Country:
China
Website Url:
http://www.biotheus.com
Total Employee:
51+
Status:
Active
Total Funding:
119.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Mobile Non Scaleable Content Euro Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
GeneQuantum Healthcare
GeneQuantum Healthcare is a high-tech company that focuses on the research and development of innovative Bio-therapeutics.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
LISCure Biosciences
LISCure Biosciences is a biotech company that researches and develops bacteria-mediated immunotherapy.
LYNK Pharmaceuticals
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
MabSpace Biosciences
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
RNAimmune
RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Employees Featured
Founder
Investors List
Huajin Financial International Holdings
Huajin Financial International Holdings investment in Series B - Biotheus
Shiyu Capital
Shiyu Capital investment in Series B - Biotheus
New Alliance Capital
New Alliance Capital investment in Series B - Biotheus
CPE
CPE investment in Series B - Biotheus
IDG Capital
IDG Capital investment in Series B - Biotheus
Highlight Capital
Highlight Capital investment in Series B - Biotheus
General Atlantic
General Atlantic investment in Series B - Biotheus
Kunlun Capital
Kunlun Capital investment in Series B - Biotheus
HLC Equity
HLC Equity investment in Series B - Biotheus
Cowin Capital
Cowin Capital investment in Series B - Biotheus
Official Site Inspections
http://www.biotheus.com
- Host name: 120.133.60.61
- IP address: 120.133.60.61
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai

More informations about "Biotheus"
Biotheus - Crunchbase Company Profile & Funding
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»
Biotheus
BiotheusIn the future, Biotheus will quickly become the first echelon of domestic biopharmaceutical companies with its high-value product chain, strong innovation capabilities, โฆSee details»
Biotheus Company Profile - Office Locations, Competitors ... - Craft
Biotheus has 5 employees across 3 locations and $114.53 m in total funding,. See insights on Biotheus including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
BioNTech Completes Acquisition of Biotheus | BioNTech
Feb 3, 2025 Biotheus will operate as a new indirect Chinese subsidiary of BioNTech, adding a local research and development hub and an advanced biologics manufacturing facility to the โฆSee details»
Biotheus Announces Strategic Research Collaboration and โฆ
Jul 20, 2023 Biotheus Inc. is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies and cell therapies to address the unmet medical โฆSee details»
Biotheus Inc. (CN) - life-sciences-asia.com
Biotheus Inc. is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies and cell therapies to address the unmet medical needs of patients โฆSee details»
ImmunoPrecise Subsidiary Signs Material Transfer Agreement with โฆ
Oct 2, 2024 Under this agreement, Biotheus will receive a specialized antibody asset from Talem Therapeutics, a subsidiary of ImmunoPrecise Antibodies. Biotheus plans to use this โฆSee details»
BioNTech Completes Acquisition of Biotheus - drug-dev.com
Biotheus will operate as a new indirect Chinese subsidiary of BioNTech, adding a local research and development hub and an advanced biologics manufacturing facility to the Companyโs โฆSee details»
BioNTech Completes Acquisition of Biotheus to Enhance Oncology โฆ
Feb 3, 2025 Biotheus will operate as a new indirect Chinese subsidiary of BioNTech, adding a local research and development hub and an advanced biologics manufacturing facility to the โฆSee details»
BioNTech to Acquire Biotheus to Boost Oncology Strategy
Nov 13, 2024 About Biotheus Biotheus is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies to address the unmet medical needs โฆSee details»
Biotheus
Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech ZHUHAI, China, July 19, 2023 /PRNewswire/ -- Biotheus Inc. ("Biotheus"), a clinical โฆSee details»
Biotheus - Funding, Financials, Valuation & Investors
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»
BioNTech Completes Acquisition of Biotheus - pharmiweb.jobs
Feb 4, 2025 BioNTech SE (Nasdaq: BNTX, โBioNTechโ or โthe Companyโ) announced today the completion of the acquisition of Biotheus (โBiotheusโ), a clinical-stage biotechnology company โฆSee details»
Biotheus - Contacts, Employees, Board Members, Advisors & Alumni
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»
BioNTech to Acquire Biotheus to Boost Oncology Strategy
Nov 13, 2024 Biotheus is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies to address the unmet medical needs of patients โฆSee details»
BioNTech buys Biotheus and its Keytruda rival for $950m
Nov 13, 2024 BioNTech snaps up Chinese bispecific antibody partner Biotheus in $950m deal, claiming full control of Keytruda rival.See details»
BioNTech Completes Acquisition Of Biotheus; Boosts Oncology โฆ
Feb 3, 2025 Biotheus will now operate as an indirect Chinese subsidiary of BioNTech, expanding BioNTech's global network with a local research and development hub and an โฆSee details»
BioNTech Acquires Biotheus To Boost Oncology Strategy
On February 3, 2025, BioNTech SE (โBioNTechโ) confirmed the completion of its acquisition of biotechnology company Biotheus for an upfront payment of $800 million and up to $150 million โฆSee details»
Biotheus - Updates, News, Events, Signals & Triggers
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»
Biotheus - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Apr 27, 2025 Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»